Static vs. Dynamic Progressive Splinting for Persistent Wrist Stiffness After DRF

November 9, 2026 updated by: Al Hayah University In Cairo

Static-Progressive Versus Dynamic Low-Load Orthosis Strategies for Persistent Wrist Stiffness After Distal Radius Fracture: A Two-Arm, Parallel-Group, Assessor-Blinded, Superiority Randomized Controlled Trial

This two-arm, parallel-group, assessor-blinded, superiority randomized controlled trial compares two complete orthotic strategies for adults aged 18 to 65 years with persistent wrist stiffness at least 8 weeks after an operatively or nonoperatively managed distal radius fracture (DRF). Participants are randomized 1:1 to an optimized static-progressive orthosis strategy (repeated 30-minute end-range stress-relaxation sessions, progressing to three sessions per day) or an optimized dynamic low-load orthosis strategy (prolonged low-load stretch, target at least 6 hours per day). Both strategies are added to an identical standardized rehabilitation program of one 45-minute supervised session per week for 6 weeks plus the same home-exercise program.

Before randomization, each participant's index restricted direction (wrist flexion or extension) is fixed using a deterministic algorithm based on the ratio of affected to contralateral passive range of motion (PROM). The single confirmatory primary outcome is index-direction wrist PROM (degrees) measured by goniometry 6 weeks after randomization. It is analyzed under intention-to-treat as the baseline-adjusted mean between-group difference. Secondary outcomes include index-direction active range of motion (AROM), opposite-direction and sagittal-arc PROM/AROM, Patient-Rated Wrist Evaluation (PRWE) scores, patient satisfaction, orthosis wear-time adherence, treatment burden and resource use, formal adverse events, and transient tolerability events, assessed at baseline, 6 weeks, and 3 months.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Cairo Governorate
      • Cairo, Cairo Governorate, Egypt, 12311
        • Faculty of Physical Therapy, Al Hayah University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18 to 65 years at the time of consent.
  • Isolated distal radius fracture managed operatively or nonoperatively.
  • At least 8 weeks since fracture and medically cleared for progressive wrist stretching.
  • Persistent wrist stiffness: affected-wrist PROM in flexion and/or extension of 50% or less of the corresponding contralateral PROM at screening.
  • Documented prior rehabilitation exposure (date active wrist rehabilitation began, number of supervised visits, home-program exposure, immobilization duration).
  • Contralateral wrist suitable as a reference: no previous major fracture or surgery, neurological disorder, inflammatory arthropathy, or other condition materially limiting flexion or extension.
  • Able to use the assigned orthosis independently or with reliable caregiver assistance and to complete daily adherence logs.
  • Able to provide written informed consent.

Exclusion Criteria:

  • Complex regional pain syndrome (Budapest criteria) or suspected CRPS requiring alternative management.
  • Active fracture-healing concern, unstable fixation, nonunion or malunion awaiting a surgical decision, active infection, or open wound incompatible with orthosis use.
  • Clinically important median, ulnar, or radial nerve symptoms aggravated by stretching or orthosis compression.
  • Skin disease or allergy preventing safe orthosis wear.
  • Major wrist pathology unrelated to the fracture, or a contralateral wrist disorder that invalidates the reference measurement.
  • Concurrent treatment plan requiring another stretching orthosis during the 6-week intervention.
  • Any medical or cognitive condition preventing safe adherence to the home orthosis program.
  • Pregnancy or breastfeeding.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Static Progressive Splinting Group (SPSG)

A static-progressive turnbuckle wrist orthosis targets the prespecified index restricted direction for 6 weeks: one 30-minute session per day in Week 1, two per day in Week 2, and three per day in Weeks 3 to 6. Participants may re-tension every 5 minutes to restore a strong but tolerable stretch. This is added to the standardized rehabilitation program (one 45-minute supervised session per week plus a home-exercise program) that is identical in both arms.

A commercially available static progressive splint with a turnbuckle mechanism allowing fine-tuned adjustments in wrist flexion and extension.

Instructional materials for home use including written guidelines and an adjustment log.

One supervised 45-minute session per week for 6 weeks, delivered from a fixed checklist. Content: active and active-assisted wrist flexion/extension and forearm rotation, hand and finger mobility, progressive grip and wrist strengthening, and functional task practice. Any manual stretching or mobilization uses a fixed dose that is identical in both arms. The same written home-exercise program is provided to both arms. Orthosis fitting time is logged separately.

Experimental: Dynamic Splinting Group (DSG)

A spring-loaded dynamic wrist orthosis targets the prespecified index restricted direction for 6 weeks, with a target of at least 6 hours per day of cumulative wear after a standardized acclimation period. Tension is set by the therapist and reviewed weekly; participants do not self-escalate.

One supervised 45-minute session per week for 6 weeks, delivered from a fixed checklist. Content: active and active-assisted wrist flexion/extension and forearm rotation, hand and finger mobility, progressive grip and wrist strengthening, and functional task practice. Any manual stretching or mobilization uses a fixed dose that is identical in both arms. The same written home-exercise program is provided to both arms. Orthosis fitting time is logged separately.

Materials:

A commercially available dynamic (spring-loaded) splint designed for the wrist. An instructional manual and daily usage log for participants.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wrist Active and Passive Range of Motion (AROM/PROM)
Time Frame: Assessed at baseline, 6 weeks (post-intervention), and 3 months follow-up.

Measured using a standard goniometer, improvements in wrist flexion and extension (in degrees) are the primary indicators of treatment efficacy.

Assessed at baseline, 6 weeks (post-intervention), and 3 months follow-up.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient-Rated Wrist Evaluation (PRWE)
Time Frame: Assessed at baseline and at 6 weeks post-intervention.

The PRWE questionnaire assesses wrist pain and disability, with lower scores indicating better functional status.

Assessed at baseline and at 6 weeks post-intervention.
Patient Satisfaction
Time Frame: Collected at 6 weeks and 3 months post-intervention.

A standardized satisfaction survey measuring patients' perceived improvement and overall satisfaction with the orthotic intervention.

Collected at 6 weeks and 3 months post-intervention.
Incidence of Adverse Events
Time Frame: Continuously monitored from baseline to the 3-month follow-up.

Incidence and severity of adverse events such as skin breakdown, discomfort, or pain (≥4/10) associated with splint usage.

Continuously monitored from baseline to the 3-month follow-up.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 17, 2025

Primary Completion (Actual)

October 8, 2026

Study Completion (Actual)

October 8, 2026

Study Registration Dates

First Submitted

March 31, 2025

First Submitted That Met QC Criteria

March 31, 2025

First Posted (Actual)

April 6, 2025

Study Record Updates

Last Update Posted (Actual)

November 12, 2026

Last Update Submitted That Met QC Criteria

November 9, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • SPDS2025-03

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.